Olaparib beim metastasierten Prostatakarzinom – die PROfound-Studie

Translated title of the contribution: Olaparib for metastatic prostate cancer—the PROfound trial

Axel S. Merseburger*

*Corresponding author for this work
1 Citation (Scopus)
Translated title of the contributionOlaparib for metastatic prostate cancer—the PROfound trial
Original languageGerman
JournalUrologe
Volume59
Issue number10
Pages (from-to)1249-1250
Number of pages2
ISSN0340-2592
DOIs
Publication statusPublished - 01.10.2020

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Research Areas and Centers

  • Research Area: Luebeck Integrated Oncology Network (LION)

DFG Research Classification Scheme

  • 2.22-14 Hematology, Oncology
  • 2.22-23 Reproductive Medicine, Urology
  • 2.22-08 Pharmacy

Cite this